StockData
NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

Neuraxis, INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$7.85+0.15 (+1.95%)

Close on Oct 19, 2026

Market cap
$95.14M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q1 FY2026
Ended Mar 31, 2026
Apr 21, 2026After market close–––
Q3 FY2025
Ended Sep 30, 2025
Oct 23, 2025After market close–––
Q4 FY2024
Ended Dec 31, 2024
Jan 8, 2025Before market open$800.00K––
Q3 FY2024
Ended Sep 30, 2024
Nov 12, 2024Before market open$667.00K––
Q2 FY2024
Ended Jun 30, 2024
Aug 9, 2024Before market open$611.50K––
Q1 FY2024
Ended Mar 31, 2024
Apr 9, 2024After market close$531.50K––
Q2 FY2023
Ended Jun 30, 2023
Sep 21, 2023Before market open$646.00K$-1.21–

Press releases

Announcements Neuraxis filed with the SEC